Trinity Biotech (TRIB) Institutional Ownership $0.77 0.00 (0.00%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$0.78 +0.01 (+1.12%) As of 02/21/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Trinity Biotech (NASDAQ:TRIB)CurrentInstitutional OwnershipPercentage78.97%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$45.24KNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$4.64M Get TRIB Insider Trade Alerts Want to know when executives and insiders are buying or selling Trinity Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TRIB Institutional Buying and Selling by Quarter Trinity Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025 Renaissance Technologies LLC189,053$166K0.0%-24.4%1.047% 1/23/2025 Hunter Associates Investment Management LLC378,590$334K0.1%+5.2%0.000% 10/24/2024 Hunter Associates Investment Management LLC359,810$390K0.1%+7.8%4.722% 8/6/2024 Acadian Asset Management LLC72,110$149K0.0%-38.0%0.946% 5/17/2024 Whitefort Capital Management LP81,902$167K0.1%-80.0%1.075% 5/10/2024 Acadian Asset Management LLC116,276$237K0.0%-83.0%1.526% 5/2/2024 Hunter Associates Investment Management LLC317,810$644K0.1%-80.5%4.171% 1/31/2024 Hunter Associates Investment Management LLC1,625,900$700K0.1%-6.1%4.266% 8/15/2023 Stonehill Capital Management LLC1,512,975$1.44M0.9%-4.7%3.970% 8/7/2023 Acadian Asset Management LLC727,954$701K0.0%-2.0%1.910% Get the Latest News and Ratings for TRIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. 8/3/2023 Hunter Associates Investment Management LLC1,724,000$1.66M0.3%-2.9%4.524% 7/13/2023 Cambridge Investment Research Advisors Inc.111,400$106K0.0%N/A0.292% 5/12/2023 Aristides Capital LLC162,317$153K0.1%-26.1%0.426% 5/2/2023 Hunter Associates Investment Management LLC1,775,100$1.68M0.4%-2.7%4.658% 2/1/2023 Hunter Associates Investment Management LLC1,823,633$1.81M0.4%+1.5%4.785% 11/2/2022 Hunter Associates Investment Management LLC1,797,190$1.91M0.5%-0.6%4.716% 8/10/2022 Hunter Associates Investment Management LLC1,808,533$2.20M0.5%-25.0%6.719% 5/12/2022 Acadian Asset Management LLC815,461$862K0.0%-3.3%3.901% 5/11/2022 Highbridge Capital Management LLC1,151,610$1.22M0.0%N/A5.510% 4/26/2022 Hunter Associates Investment Management LLC2,412,116$2.56M0.8%+5.5%11.540% 2/14/2022 Stonehill Capital Management LLC219,946$315K0.1%-55.0%1.052% 2/14/2022 Whitefort Capital Management LP35,068$50K0.0%N/A0.168% 2/10/2022 Acadian Asset Management LLC843,523$1.20M0.0%-1.4%4.036% 2/4/2022 Envestnet Asset Management Inc.110,901$159K0.0%N/A0.531% 1/27/2022 Hunter Associates Investment Management LLC2,286,150$3.27M0.9%+9.1%10.937% 11/18/2021Wealthsource Partners LLC30,200$65K0.0%N/A0.144% 11/15/2021 Marshall Wace LLP34,703$75K0.0%-37.5%0.166% 11/15/2021 Hunter Associates Investment Management LLC2,095,900$4.53M1.5%+2.0%10.027% 11/12/2021 Renaissance Technologies LLC1,746,841$3.77M0.0%-5.6%8.357% 10/28/2021 Navellier & Associates Inc.15,485$33K0.0%-84.6%0.074% 8/25/2021 Marshall Wace LLP55,557$163K0.0%-38.7%0.266% 8/16/2021 Marshall Wace LLP55,557$163K0.0%-38.7%0.266% 8/13/2021 Renaissance Technologies LLC1,850,082$5.44M0.0%+0.3%8.851% 8/13/2021 LPL Financial LLC60,073$177K0.0%+171.5%0.287% 8/9/2021 Navellier & Associates Inc100,611$296K0.0%+23.1%0.481% 5/19/2021 Squarepoint Ops LLC36,450$137K0.0%N/A0.174% 5/18/2021 Millennium Management LLC59,019$222K0.0%-39.5%0.282% 5/17/2021 HRT Financial LP14,100$53K0.0%N/A0.067% 5/13/2021 Renaissance Technologies LLC1,844,963$6.94M0.0%-3.2%8.827% 5/12/2021 Navellier & Associates Inc81,746$307K0.1%+25.8%0.391% Warning: China Launches AI Attack on America (Ad)If you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary investor who picked Nvidia before shares exploded as high as 3,423%... Before April 30th, President Trump could make a shocking AI announcement... Sending these stocks exploding higher.5/11/2021 Acadian Asset Management LLC753,293$2.83M0.0%+20.6%3.604% 5/10/2021 Hunter Associates Investment Management LLC1,642,959$6.18M1.4%-2.3%7.860% 4/27/2021 State of New Jersey Common Pension Fund D27,062$102K0.0%N/A0.129% 2/24/2021 Virtu Financial LLC29,898$114K0.0%+17.1%0.124% 2/16/2021 Stonehill Capital Management LLC992,614$3.78M1.1%-27.3%4.129% 2/13/2021Wealthsource Partners LLC30,000$114K0.0%+7.5%0.125% 2/10/2021 Renaissance Technologies LLC1,906,806$7.27M0.0%+13.8%7.932% 2/10/2021 Mackenzie Financial Corp21,100$80K0.0%N/A0.088% (Data available from 1/1/2016 forward) TRIB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TRIB shares? During the previous two years, the following institutional investors and hedge funds held shares of Trinity Biotech shares: Stonehill Capital Management LLC ($1.44M), Hunter Associates Investment Management LLC ($334K), Whitefort Capital Management LP ($167K), Renaissance Technologies LLC ($166K), Aristides Capital LLC ($153K), and Acadian Asset Management LLC ($149K), and Cambridge Investment Research Advisors Inc. ($106K).Learn more on TRIB's institutional investors. What percentage of Trinity Biotech stock is owned by institutional investors? 78.97% of Trinity Biotech stock is owned by institutional investors. Learn more on TRIB's institutional investor holdings. Which institutional investors have been buying Trinity Biotech stock? The following institutional investors have purchased Trinity Biotech stock in the last 24 months: Cambridge Investment Research Advisors Inc. ($111.40K), and Hunter Associates Investment Management LLC ($44.88K). How much institutional buying is happening at Trinity Biotech? Institutional investors have bought a total of 156,280 shares in the last 24 months. This purchase volume represents approximately $575.00K in transactions. Which Trinity Biotech major shareholders have been selling company stock? The following institutional investors have sold Trinity Biotech stock in the last 24 months: Hunter Associates Investment Management LLC ($1.51M), Acadian Asset Management LLC ($627.37K), Whitefort Capital Management LP ($327.62K), Stonehill Capital Management LLC ($75K), Renaissance Technologies LLC ($61.10K), and Aristides Capital LLC ($57.21K). How much institutional selling is happening at Trinity Biotech? Institutional investors have sold a total of 2,662,518 shares in the last 24 months. This volume of shares sold represents approximately $6.04M in transactions. Related Companies Immix Biopharma Institutional Ownership Lantern Pharma Institutional Ownership Repare Therapeutics Institutional Ownership Prelude Therapeutics Institutional Ownership KALA BIO Institutional Ownership Connect Biopharma Institutional Ownership Celularity Institutional Ownership Xilio Therapeutics Institutional Ownership Dyadic International Institutional Ownership AlloVir Institutional Ownership This page (NASDAQ:TRIB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trinity Biotech plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Trinity Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
